Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Electric Bicycle Americans Can Confide in 202405.06.2024 - 2Bestselling author Colleen Hoover reveals cancer journey13.01.2026
- 3Turning into a Distributed Writer: My Composing Process25.09.2023
- 4Vote In favor of Your Number one Savvy Beds01.01.1
- 5FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access03.12.2025
- Vote In favor of Your Favored Treat
- Courageous Climbing: Trails and Stuff for Outside Lovers
- Instructions to Choose the Best Web based Advertising Degree Program for Your Objectives
- How to watch 'Tell Me Lies' Season 3: Episode release times, streaming info and more
- Antivirus Programming for Exhaustive Security
- Extravagance SUVs for Seniors: Solace, Innovation, and Security
- Figure out How to Pick a Crematorium: Key Contemplations.
- Hungary's 'water guardian' farmers fight back against desertification
- The most effective method to Offset Album Rates with Liquidity Needs
